Novolog Pharm-Up 1966 Ltd
NVLG.TA
| Exchange: | TA |
| Currency | Israeli Agora |
| ISIN: | IL0011401515 |
| Primary Ticker: | NVLG.TA |
| Fiscal Year End: | December |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Medical Distribution |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Providers & Services |
| Gic Sub Industry: | Health Care Distributors |
| Description: | Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of medicine and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Health Services division provides customized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel. |
| Address: | 55 Ma'ayan Street, Modi'in-Maccabim-Re'ut, Israel, 7171301 |
| Website: | https://www.novolog.co.il |
| Full Time Employees: | 955 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 771739904 |
| Market Capitalization Mln: | 771.73 |
| EBITDA: | 126311000 |
| Wall Street Target Price: | 2.1 |
| Book Value: | 0.74 |
| Dividend Share: | 0.05 |
| Dividend Yield: | 0.03 |
| Earnings Share: | -0.03 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.01 |
| Operating Margin TTM: | 0.04 |
| Return On Assets TTM: | 0.01 |
| Return On Equity TTM: | -0.03 |
| Revenue TTM: | 1683250048 |
| Revenue Per Share TTM: | 3.29 |
| Quarterly Revenue Growth YOY: | 0.03 |
| Gross Profit TTM: | 176226000 |
| Diluted Eps TTM: | -0.03 |
| Quarterly Earnings Growth YOY: | 0.1 |
Valuation
| Price Sales TTM: | 0.45 |
| Price Book MRQ: | 2.05 |
| Enterprise Value: | 753246060 |
| Enterprise Value Revenue: | 0.44 |
| Enterprise Value Ebitda: | 5.55 |
Shares
| Shares Outstanding: | 510748000 |
| Shares Float: | 330357938 |
| Percent Insiders: | 35.31 |
| Percent Institutions: | 51.23 |
Technicals
| Beta: | 0.37 |
| 52 Week High: | 170 |
| 52 Week Low: | 122.55 |
| 50 Day MA: | 150.67 |
| 200 Day MA: | 149.36 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.06 |
| Forward Annual Dividend Yield: | 0.03 |
| Payout Ratio: | 2.18 |
| Ex Dividend Date: | 2024-09-03 |